Resources

Understanding Long COVID-19

Product: — Evidence Synthesis Network

About Coronavirus Disease Mechanism Epidemiology Infectious Diseases & Clinical Care Long Covid

esnetwork.ca Last Updated: October 29, 2021

Evidence-Based Use of Therapeutics for Ambulatory Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: October 18, 2021

Evidence-Based Recommendations on the Use of Casirivimab + Imdevimab, and Sotrovimab for Adults in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 30, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 30, 2021

Best Practices for Case and Contact Management of COVID-19

Product: — Evidence Synthesis Network

About Coronavirus Infectious Diseases & Clinical Care Practice Guidelines Public Prevention

esnetwork.ca Last Updated: September 23, 2021

CADTH Health Technology Review: Sotrovimab for the Treatment of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Infectious Diseases & Clinical Care Treatments

covid.cadth.ca Last Updated: September 15, 2021

Also available in Français

Understanding the Post COVID‑19 Condition (Long COVID) and the Expected Burden for Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 14, 2021

The Incidence, Severity, and Management of COVID‑19 in Critically Ill Pregnant Individuals

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 13, 2021

The Impact of the COVID‑19 Pandemic on Opioid-Related Harm in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 8, 2021

Heparin Anticoagulation for Hospitalized Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 3, 2021